43
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Advanced lung adenocarcinoma with spinal cord metastasis successfully treated with second EGFR-TKI treatment: a case report and literature review

, , &
Pages 2739-2743 | Published online: 29 Sep 2015

References

  • LiWZhouFZhouCRole of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patientsOncoTargets Ther20147253261
  • HataYTakaiYTakahashiHComplete response of 7 years’ duration after chemoradiotherapy followed by gefitinib in a patient with intramedullary spinal cord metastasis from lung adenocarcinomaJ Thorac Dis201352E65E6723585962
  • ShahLMSalzmanKLImaging of spinal metastatic diseaseInt J Surg Oncol2011201176975322312523
  • ZengZChenHJYanHHYangJJZhangXCWuYLSensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutationsInt J Biol Markers2013283249258
  • ChoBCImCKParkMSPhase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinibJ Clin Oncol200725182528253317577030
  • LeeDHKimSWSuhCYoonDHYiEJLeeJSPhase II study of erlotinib as a salvage treatment for non-small-cell lung cancer patients after failure of gefitinib treatmentAnn Oncol200819122039204218644828
  • LeeDSKwakYKJeongSMHigh-dose radiotherapy using helical tomotherapy for vertebral metastasis: early clinical outcomes and cord dose specificationJpn J Clin Oncol201343664665323613190
  • XuSYuXXuMLong-term survival of a patient with lung cancer metastasis to the spine following surgical treatment combined with radiation and epithelial growth factor receptor inhibitor therapy: a case reportExp Ther Med20159111711925452785
  • ZhangYTangHLiJLiMAn active treatment of lung adenocarcinoma cancer with brain metastases: icotinibOncoTargets Ther2015813511354
  • TogashiYMasagoKFukudoMEfficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutationCancer Chemother Pharmacol20116841089109221681573
  • WeberBWinterdahlMMemonAErlotinib accumulation in brain metastases from non-small cell lung cancer: visualization by positron emission tomography in a patient harboring a mutation in the epidermal growth factor receptorJ Thorac Oncol2011671287128921847041
  • ShaozhangZMingZHaiyanPAipingZQitaoYXiangqunSComparison of ARMS and direct sequencing for detection of EGFR mutation and prediction of EGFR-TKI efficacy between surgery and biopsy tumor tissues in NSCLC patientsMed Oncol201431592624748405
  • AkcaHDemirayAYarenAUtility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancerCancer Genet20132063738023491080
  • KimSTJungHYSungJSCan serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer?Am J Clin Oncol2013361576322237146
  • SongZYuXHeCZhangBZhangYRe-administration after the failure of gefitinib or erlotinib in patients with advanced non-small cell lung cancerJ Thorac Dis20135440040523991294
  • TangCGaoHLiXDifferent treatment orders achieved similar clinical results: a retrospective study for retreatment of epidermal growth factor receptor tyrosine kinase inhibitors in 120 patients with non-small-cell lung cancerJ Cancer Res Clin Oncol2014140342743324401995